RGEN

Repligen Corporation

RGEN.US repligen.com + Research + Basket
CIK 0000730272
Employees 2,000
Phone 781 250 0111
Fiscal year end December
IPO Mar 26, 1990
Address Building 1, Waltham, MA, United States, 02453
178.20
-0.07 (-0.04%)
USD · NASDAQ
52-week range
100.99
198.87
Trading at 79% of the 52-week range
Market Cap
11.40B
P/E Ratio
0.00
Forward P/E
62.11
Book Value
36.90
Div. Yield
N/A
% Institutions
105.32%
% Insiders
4.63%

1 Year

+21.3%

3 Year

+23.8%

10 Year

+548.5%
Description

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Actions

Add an action for RGEN.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Olivier Loeillot President, CEO & Director 1970
Mr. Jason K. Garland CFO & Chief Compliance Officer 1974
Mr. James R. Bylund Chief Operating Officer 1963
Mr. Anthony J. Hunt Advisor 1964
Mr. Ralf Kuriyel Senior Vice President of Research & Development 1958
Mr. Brian Robb Douglass Senior VP & Chief Product Officer 1975
Dr. Paul R. Schimmel Ph.D. Founder 1941
Ms. Violetta Hughes Chief Accounting Officer 1973
Ms. Heather Ems Chief Information Officer NA
Mr. Jacob K. Johnson C.F.A. Vice President of Investor Relations NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 17, 2025 Karen A Dawes N/A Sale 275.00 $161.00 $44.28K SEC
Nov 18, 2025 James Bylund N/A Sale 2.19K $151.21 $331.30K SEC
Nov 18, 2025 James Bylund N/A Sale 2.19K $151.21 $331.30K SEC
Nov 13, 2025 Anthony Hunt N/A Sale 20.00K $154.61 $3.09M SEC
Nov 12, 2025 Anthony Hunt N/A Sale 25.00K $156.88 $3.92M SEC
Oct 31, 2025 Lisa C. McClain N/A Sale N/A $149.06 N/A —
Oct 30, 2025 Lisa C. McClain N/A Sale N/A $144.57 N/A —
Oct 30, 2025 Lisa C. McClain N/A Purchase N/A $144.57 N/A —
Aug 08, 2025 Martin D Madaus N/A Purchase 1.80K $112.13 $201.83K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 5.38M Jun 30, 2026 8.48% $0.01 -10.15%
FMR Inc 3.33M Jun 30, 2026 5.24% $0.02 15.24%
United Capital Financial Advisers Inc 2.79M Jun 30, 2026 4.40% $2.10 0.60%
Vanguard Capital Management, LLC 2.41M Jun 30, 2026 3.80% $0.01 0.61%
Vanguard Portfolio Management, LLC 2.31M Jun 30, 2026 3.64% $0.01 0.34%
Maverick Capital Ltd 1.98M Jun 30, 2026 3.13% $2.39 30.67%
State Street Corp 1.80M Jun 30, 2026 2.84% $0.01 1.31%
T. Rowe Price Associates, Inc. 1.75M Jun 30, 2026 2.76% $0.02 -64.08%
Massachusetts Financial Services Company 1.62M Jun 30, 2026 2.55% $0.07 15.71%
Wasatch Advisors LP 1.59M Jun 30, 2026 2.50% $1.42 27.88%
Ameriprise Financial Inc 1.58M Jun 30, 2026 2.48% $0.04 70.35%
Bank of New York Mellon Corp 1.52M Jun 30, 2026 2.40% $0.03 -0.56%
T. Rowe Price Investment Management,Inc. 1.41M Jun 30, 2026 2.22% $0.13 3.29%
Amvescap Plc. 1.39M Jun 30, 2026 2.19% $0.02 8.53%
Holocene Advisors, LP 1.29M Jun 30, 2026 2.04% $0.40 82.28%
RTW INVESTMENTS, LLC 1.24M Jun 30, 2026 1.95% $1.45 2.87%
Geode Capital Management, LLC 1.06M Jun 30, 2026 1.67% $0.01 -0.19%
Congress Asset Management Company, LLP 1.01M Jun 30, 2026 1.59% $0.85 26.87%
Conestoga Capital Advisors, LLC 980.98K Jun 30, 2026 1.55% $2.91 -10.64%
The Goldman Sachs Group Inc 965.41K Jun 30, 2026 1.52% $0.01 48.22%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 2.26M 3.53% ▲ 0.10% Oct 29, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 1.71M 2.67% ▲ 0.28% Sep 30, 2026
3 Vanguard Small Cap Index 1.21M 1.89% ▼ 2.11% Sep 30, 2026
4 MFS Mid Cap Growth A 1.12M 1.75% ▲ 7.22% Sep 30, 2026
5 T. Rowe Price New Horizons 950.22K 1.49% ▼ 12.00% Sep 30, 2026
6 Invesco Discovery A 817.87K 1.28% ▲ 9.00% Aug 31, 2026
7 American Funds SMALLCAP World A 699.73K 1.09% ▲ 0.00% Sep 30, 2026
8 Wasatch Core Growth 673.98K 1.05% ▲ 35.19% Jun 30, 2026
9 Vanguard MStar Small Cap Growth Indx Inv 670.92K 1.05% ▼ 5.21% Sep 30, 2026
10 Fidelity Contrafund 586.46K 0.92% ▲ 36.37% Aug 31, 2026

Financial Highlights

▼
Market Cap: $11.40B
EBITDA: $143.50M
PEG Ratio: $1.67
Book Value: $36.90
Earnings/Share: $-0.22
Profit Margin: -1.47%
Operating Margin: 6.19%
ROA (TTM): 1.40%
ROE (TTM): -0.57%
Revenue (TTM): $805.61M
Revenue/Share (TTM): $14.28
Earnings Growth (YOY): -65.90%
Revenue Growth (YOY): 10.90%

Valuation Metrics

Enterprise Value: $10.81B
Trailing P/E: 0.00
Forward P/E: 62.11

Shares Statistics

Shares Outstanding: 63.92M
Shares Float: 60.58M
% Insiders: 4.63%
% Institutions: 105.32%
Shares Short: 7.15M
Shares Short (Prior Month): 7.58M
Short Ratio: 5.48
Short % Float: 11.28%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$738.26M
Cost of Goods Sold
adjust
$-390.63M
Gross Profit
subtotal
$347.62M
SG&A
adjust
$-290.51M
R&D
adjust
$-54.18M
Operating Income
subtotal
$59.58M
Other / Non-Operating Items
adjust
$-10.68M
Net Income
subtotal
$48.89M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RGEN.US!